SCHEMBL1629172

SCHEMBL1629172

COc1cc(OC)c(-c2ccnn2-c2ccccc2Cl)cc1NCc1ccccc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
P2RX7 Q99572 6/20 0.41
MAPT P10636 4/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
ATM Q13315 1/20 0.38
SUV39H2 Q9H5I1 1/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2C19 P33261 2/20 0.38
TP53 P04637 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
HIF1A Q16665 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1630477 0.84 HSP90AA1 (0.51) HSP90AA1L3MBTL1MAPTMEN1KMT2A
SCHEMBL1628888 0.83 HSP90AA1 (0.57) HSP90AA1L3MBTL1P2RX7MAPTMEN1
SCHEMBL1629208 0.79 P2RX7 (0.43) HSP90AA1P2RX7MAPTMEN1KMT2A
SCHEMBL1629065 0.77 NFE2L2 (0.42) HSP90AA1MAPTLMNA
SCHEMBL1629067 0.77 NFE2L2 (0.42) HSP90AA1MAPTLMNA
SCHEMBL1630234 0.76 ALDH1A1 (0.48) MAPTKMT2ATP53TSHRALDH1A1
SCHEMBL1628606 0.76 HSP90AA1 (0.41) HSP90AA1MAPTKMT2ATP53TSHR
SCHEMBL1629896 0.75 KCNN4 (0.44) HSP90AA1MAPT
SCHEMBL1629564 0.75 HSP90AA1 (0.44) HSP90AA1P2RX7MAPTATMMAPK1
SCHEMBL12722876 0.75 HSP90AA1 (0.46) HSP90AA1P2RX7MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed
EP-1776346-A1 1,5-DIPHENYLPYRAZOLES Merck Patent GmbH (DE) 2007-04-25 EP disclosed
WO-2006018082-A1 1,5-DIPHENYLPYRAZOLES MERCK PATENT GMBH (DE) 2006-02-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885L3MBTL1 1226/4885P2RX7 2214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.